BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Merck
Citi
US Department of Justice
Fish and Richardson
Moodys
Boehringer Ingelheim
Julphar
Johnson and Johnson

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,691,374

« Back to Dashboard

Summary for Patent: 5,691,374
Title: Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors
Abstract:The invention encompasses the novel compound of Formula I as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
Inventor(s): Black; Cameron (Point Claire, CA), Grimm; Erich (Baie D'Urfe, CA), Wang; Zhaoyin (Pierrefonds, CA), Leger; Serge (Dollard des Ormeaux, CA)
Assignee: Merck Frosst Canada Inc. (Kirkland, CA)
Application Number:08/443,620
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

Drugs Protected by US Patent 5,691,374

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,691,374

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 5642496 ➤ Subscribe
Canada 2219129 ➤ Subscribe
Germany 69617676 ➤ Subscribe
Denmark 0828724 ➤ Subscribe
Australia 707773 ➤ Subscribe
Austria 210124 ➤ Subscribe
European Patent Office 0828724 ➤ Subscribe
Spain 2168471 ➤ Subscribe
Japan H11505534 ➤ Subscribe
Portugal 828724 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Merck
Baxter
Argus Health
Fuji
Cantor Fitzgerald
Federal Trade Commission
Julphar
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot